Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 24 September 2027
- Last conf. stmt
- 10 September 2026
Glaxosmithkline Holdings Limited
- Incorporated
- 7 December 2005 (20 years)
- Industry
- Activities of head offices (70100)
- Directors
- Alistair Robert Davidson
- Owned by
- Accounts type
- Full
- Region
- Greater London
- Address
- 79 New Oxford StreetLondonWC1A 1DG
Officers 4 active
Officer details are public data from the Companies House register.
Davidson, Alistair Robert
Director · Appointed 31 December 2025
British
Born December 1972 (53)
Corporate Secretary · Appointed 19 January 2006
Corporate Director · Appointed 19 January 2006
Corporate Director · Appointed 19 January 2006
Officer history (9 former)
31 December 2025
Appointed Davidson, Alistair Robert as Director
31 December 2025
2 March 2020
2 March 2020
1 May 2019
15 February 2019
1 April 2011
31 March 2011
19 January 2006
19 January 2006
19 January 2006
19 January 2006
19 January 2006
19 January 2006
19 January 2006
12 January 2006
12 January 2006
12 January 2006
12 January 2006
7 December 2005
7 December 2005
7 December 2005
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 3888792
Group structure 22 shown
Ownership group derived from the Companies House PSC register
British Pharma Group Limited Holds 25–50% of voting rights
Glaxosmithkline Holdings (One) Limited Owns 75–100% of shares
Glaxosmithkline Holdings Limited This company Owns 75–100% of shares
Glaxosmithkline Finance PLC Owns 75–100% of shares
Glaxo Group Limited Owns 75–100% of shares
Glaxosmithkline Ihc Limited Owns 75–100% of shares
GSK Finance (No 2) Limited Owns 75–100% of shares
Setfirst Limited Owns 75–100% of shares
Smithkline Beecham Limited Owns 75–100% of shares
Wellcome Limited Owns 75–100% of shares
Glaxosmithkline Mercury Limited Owns 75–100% of shares
Viiv Healthcare Limited Owns 75–100% of shares
Viiv Healthcare Finance 2 Limited Owns 75–100% of shares
Viiv Healthcare Overseas Limited Owns 75–100% of shares
Viiv Healthcare Trading Services UK Limited Owns 75–100% of shares
Viiv Healthcare UK (No.4) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.5) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.6) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.7) Limited Owns 75–100% of shares
Viiv Healthcare UK Limited Owns 75–100% of shares
Glaxosmithkline Services Unlimited Owns 75–100% of shares
Filings 98
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 September 2026 | Confirmation statement with no updates | 10 September 2026 | ||
| 30 May 2026 | Full accounts | 31 December 2025 | ||
| 6 January 2026 | Appointment of a director | |||
| 6 January 2026 | Termination of appointment of a director | |||
| 22 September 2025 | Confirmation statement with no updates | 22 September 2025 |
Some other companies at this address
Other companies in this industry
London
Theale
Bedford
Ruislip
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →